Skip to main content
AGL logo

AGL · agilon health, inc. · Holdings

Track AGL — free
$89.71 -0.58 (-0.64%) At close · Oct 23
Market Cap
$1.51B
Shares
16.79M
Volume · Oct 23 189.62K Avg daily vol (3M) 264.17K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Recent SEC filings are still being reconciled. Holder totals and changes may be incomplete until processing catches up.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 184
Total Value: $1,817,035,466
Total Shares: 17,299,980
Showing 1–100 of 196 holdings by value · page 1 of 2

Institutional Ownership Trend

22 quarters

Holder Concentration

Across 180 13F filers
Top Holder
23.6%
Sep 2023 → Jun 2026 · range 21.7% – 26.5%
of institutional value
Top 5
55.0%
Sep 2023 → Jun 2026 · range 55.0% – 70.3%
of institutional value
Top 10
70.0%
Sep 2023 → Jun 2026 · range 70.0% – 87.5%
of institutional value
HHI
912
Sep 2023 → Jun 2026 · range 912 – 1,165
Broadly held

Who Holds AGL

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 179 filers, like-for-like change +4.9%; actively managed books +13.7%; index-like books +1.9%.

Holder type Share Filers Change
Registered adviser 56.2% 102 -5.8%
Exempt adviser 3.0% 3 new
Adviser 3.8% 4 +773.7%
Bank 3.7% 14 +24.0%
Insurer 0.1% 1 new
Broker-dealer 0.1% 2 +673.6%
Benefit plan 0.1% 4 +2.2%
Non-US 0.3% 7 -27.6%
Holding company 24.3% 7 -2.7%
Unknown 8.4% 35 +24.3%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 2 holders with no observed 2026-06-30 13F.

Conviction and Crowding

179 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
4
2.23% of filers hold it in their top 10
Mar 31, 2026: 3
Holders above 5%
3
median weight 0.003%
Mar 31, 2026: 1
Crowding
52.8%
of shares outstanding, 98th percentile
Mar 31, 2026: 54.2%
Private-fund advisers
48.1%
of shares outstanding
Institutional ownership
97.0%
103.1% of the estimated free float above 100%: filers can report lent or client shares more than once
Top 10 holders
73.2%
of 13F shares, Herfindahl 0.099
Active holders
+13.7%
like-for-like share change of active filers
5% stakes on record
4
0 13D, 4 13G (2 institutional, 1 passive, 1 exempt)
How long holders have held it value-weighted 13.1 quarters
Under 1 year 18.0% 1 to 3 years 30.1% 3 years or more 51.9% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$539.10
estimated per share
Mar 31, 2026: $598.58
Quarter-end price
$107.10
implied by 13F values
Estimated gain or loss
-80.1%
price against the estimated cost
Estimated at a loss
70.4%
of costed 13F value

Estimated cost covers 52.8% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies AGL's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 AMN Amn Healthcare Services Inc 4
2 EYPT EyePoint, Inc. 3
3 ORKA Oruka Therapeutics, Inc. 4
4 OCUL Ocular Therapeutix, Inc 3
5 ERAS Erasca, Inc. 3
6 MLYS Mineralys Therapeutics, Inc. 3
7 CLDX Celldex Therapeutics, Inc. 3
8 GPCR Structure Therapeutics Inc. 3
9 XENE Xenon Pharmaceuticals Inc. 3
10 INSM INSMED Inc 4

Shareholder Targets

13F filers that own its peers but not AGL, quarter ended Jun 30, 2026

Found through its holder-overlap peers: AMN, EYPT, ORKA, OCUL, ERAS, MLYS, CLDX, GPCR, XENE, INSM, VKTX, ASND, MOH, THC, ALNY, TECH, CVNA, NBIX, RVMD, CNC. 2,062 filers in all.

# Filer In peers
1 Capital Research Global Investors Adviser, Diversified active $7,544,814,516 4 held
2 Capital World Investors Adviser, Diversified active $6,436,707,967 12 held
3 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $4,611,860,498 10 held
4 Jupiter Topco LLC Unknown, Diversified active $4,190,165,287 20 held
5 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $3,915,613,418 18 held
6 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $3,224,187,792 5 held
7 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $3,097,782,004 3 held
8 Capital International Investors Adviser, Diversified active $3,082,125,014 4 held
9 NORGES BANK Non-US, Index-like $2,862,579,513 9 held
10 Darwin Global Management, Ltd. Exempt adviser, Concentrated $2,676,443,663 2 held

Fund Ownership of AGL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.62% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.75% 461,552
Index ETFs 8.87% 1,488,859
Active ETFs 0.13% 21,338
Active funds 9.07% 1,522,255
Unclassified 0.03% 4,937
All registered funds 20.84% 3,498,941
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Showing 100 of 196
Export CSV
Holder Value (USD) % of 13F Shares Open

Showing the top 100 of 196 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1831097 CUSIP 00857U206 13F (30d) 23 filings 23 filers Visit website Investor relations